Skip to Main Content

Paper Details

A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic <i>BRAF</i>-Mutant Colorectal Cancer.
Cancer Discov
171
2017
Author NameAffiliation
Martijn P LolkemaUniversity Medical Center Utrecht
Martijn P LolkemaErasmus MC Cancer Institute
Sunil SharmaHuntsman Cancer Institute, University of Utah
Jan H M SchellensThe Netherlands Cancer Institute
Jan H M SchellensUtrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
  • 1 - 5

Datasets

Release 1.2